Thyroid cancer is the most common endocrine malignancy. Differentiated thyroid cancer
(DTC) with the two subtypes, papillary thyroid cancer (PTC) and follicular thyroid cancer …

The main clinical challenge in the management of thyroid cancer is to avoid over-treatment
and over-diagnosis in patients with lower-risk disease while promptly identifying those …

Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Risk assessment is the cornerstone of contemporary management of thyroid cancer.
Following thyroid surgery, an initial risk assessment of recurrence and disease-specific …

Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3%
of global cancer incidence. Different histologies and clinical scenarios make necessary a …

The concept of individualized therapy is rapidly gaining recognition in the management of
patients with differentiated thyroid cancer (DTC). This Review provides an overview of the …

Risk adapted treatment recommendations are dependent on accurate predictions of the risk
of recurrence, risk of death, and likely sites of recurrence. When combined with response to …

Thyroid cancer is increasing all over the world. The exact cause of this increase is still
debated and there are conflicting reports. Sophisticated molecular studies suggest that …

Differentiated thyroid cancer (DTC) has become one of the most frequently diagnosed
malignancies, especially among women and young adults (Davies & Welch 2014). The …

Thyroid cancer is a common endocrine malignancy, which histologically includes follicular
epithelial cell–derived thyroid cancer and parafollicular C-cell–derived medullary thyroid …